| Website | svlsa.com |
| Phone | 650-571-8200 |
| Employees | |
| Description | Venture capital Firm |
SV Life Sciences is a venture capital adviser and manager that makes selected investments in entrepreneurs and management teams.
SV Life Sciences provides finance to businesses at all stages of development and across the human life sciences sector. These sectors range from biotechnology & pharmaceuticals to medical devices & instruments, to healthcare information technology and services. SV Life Sciences currently advises or manages five funds with capital commitments of approximately $1.5 billion which primarily invest amounts of between $1m and $40m in North America and Europe, but will consider innovative investments in other regions. Our team of 34 professionals has a diverse, complimentary set of skills and experience that allow us to tailor a team to work with almost any life sciences business.
| Company | Date | Round | Size | Participants |
| Entellus Medical | 11/09 | Series D | $30M | 3 |
| Lux Biosciences | 10/09 | Series B | $50M | 4 |
| ValenTx | 10/09 | Series B | $20.3M | 6 |
| Juvaris BioTherapeutics | 9/09 | Series B | $25M | 2 |
| Cadent | 8/09 | Unattributed | $15M | 5 |
| Ocular Therapeutix | 6/09 | Series C | $15M | 3 |
| Sadra Medical | 5/09 | Series C | $30M | 7 |
| Sutro Biopharma | 3/09 | Series B | $15M | 2 |
| NKT Therapeutics | 3/09 | Series A | $8M | 2 |
| LensX Lasers | 3/09 | Series B | $22.4M | 3 |
| ReShape Medical | 2/09 | Series B | $20M | 3 |
| ESBATech | 8/08 | Series B | $22M | 7 |
| EBR Systems | 6/08 | Series C | $35M | 5 |
| Entellus Medical | 5/08 | Series C | $15M | 3 |
| Fundamental Applied Biology | 12/07 | Series B | $21M | 2 |
| Entellus Medical | 5/07 | Series B | $9M | 2 |
| NeoVista | 12/06 | Series C | $41M | 6 |
| Sadra Medical | 10/06 | Series B | $19M | 5 |
| NeoVista | 9/06 | Series B | $26M | 4 |
| Entellus Medical | 4/06 | Series A | $3M | 2 |
